Accueil   Diary - News   All news EU Lead Factory and CELLIPSE achieve 1st Collaboration Milestone

EU Lead Factory and CELLIPSE achieve 1st Collaboration Milestone

European Lead Factory (ELF) and CELLIPSE announced today completion of the 1st phase of their collaboration program to identify hits against an undisclosed innovative therapeutic target that is involved in cytoskeleton regulation.

 

The qualified hit list delivered to CELLIPSE was obtained from a screening program on ELF’s Joint European Chemical Library that included more than 400,000 (now 450,000) compounds.

 

Read the press release

Cellipse

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree